We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Integrated LAMP and Immunoassay Platform Detect Diarrheal Disease

By LabMedica International staff writers
Posted on 26 Sep 2018
The challenges of diagnosing infectious disease, especially in the developing world, and the shortcomings of available instrumentation have exposed the need for portable, easy-to-use diagnostic tools capable of detecting the wide range of causative microbes while operating in low resource settings.

There are approximately 1.7 billion cases of diarrheal disease globally each year, and the syndrome is frequently caused by infections. More...
Children are particularly vulnerable; diarrheal disease kills more than half a million children worldwide each year, and is the second leading cause of death in children under the age of five. It also represents a significant unmet diagnostic need, particularly in the developing world.

Biotechnologists at the Sandia National Laboratories (Livermore, CA, USA) have developed a syndromic test that combines immunoassays and isothermal amplification-based molecular testing. Essentially a small, fully integrated syndromic panel, the test can go from stool sample to result using the next generation of a platform developed at Sandia called SpinDx. The SpinDx system, a centrifugal microfluidics diagnostics platform with integrated sample preparation. Among other enhancements, the newest version now incorporates non-contact temperature control using a medium-wave infrared heater.

The assay can detect three protein-based enterotoxins as well as DNA of three enteric pathogens. Specifically, it detects cholera toxin, Staphylococcal enterotoxin B, and Shiga-like toxin 1, as well as Campylobacter jejuni, Escherichia coli, and Salmonella typhimurium, in less than one hour. A panel of LAMP reactions was developed for the detection of C. jejuni E. coli, and S. typhimurium. In order to determine the limit of detection of the immunoassays, toxin solutions were diluted to concentrations of 1,000, 300, 100, 30, 10, 3 and 0 ng/mL and each was run in triplicate – with the exception of the highest concentration, which was run in duplicate.

The authors concluded that the core feature of the platform enabled multiplexed detections without the burdensome complexity found in similar centrifugal microfluidic devices is the non-contact heating system. The advantages of this system, in which the heat source is spatially separate from the disc, are numerous, including the viability of a simple, low-cost disc, since features such as embedded heating elements or actuation systems for bringing a heater into contact with the disc are not needed. The study was published originally published online on August 10, 2018, in the journal Biosensors and Bioelectronics.

Related Links:
Sandia National Laboratories


Gold Member
Immunochromatographic Assay
CRYPTO Cassette
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Gold Member
Hematology Analyzer
Medonic M32B
Homocysteine Quality Control
Liquichek Homocysteine Control
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image: Whole-genome sequencing enables broader detection of DNA repair defects to guide PARP inhibitor cancer therapy (Photo courtesy of Illumina)

Whole-Genome Sequencing Approach Identifies Cancer Patients Benefitting From PARP-Inhibitor Treatment

Targeted cancer therapies such as PARP inhibitors can be highly effective, but only for patients whose tumors carry specific DNA repair defects. Identifying these patients accurately remains challenging,... Read more

Pathology

view channel
Image: AI models combined with DOCI can classify thyroid cancer subtypes (Photo courtesy of T. Vasse et al., doi 10.1117/1.BIOS.3.1.015001)

AI-Powered Label-Free Optical Imaging Accurately Identifies Thyroid Cancer During Surgery

Thyroid cancer is the most common endocrine cancer, and its rising detection rates have increased the number of patients undergoing surgery. During tumor removal, surgeons often face uncertainty in distinguishing... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.